Globus Medical, Inc. (GMED) is currently Undervalued by 35.60%

Globus Medical, Inc. (GMED) appears undervalued by approximately 35.60% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.

Upside (live) 35.60% (from live valuation API)
Confidence (live) 8/10 (High)

Confidence Score is based on the magnitude of upside or downside vs intrinsic value.

Fair value estimate

Unlock fair value

Current price

$78.83

Stock valuation checker

Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.

Explore Our Valuation Calculators

Intrinsic Value Calculator (DCF)ROE Calculator Stock Valuation Calculator

Why is Globus Medical, Inc. overvalued or undervalued?

For Globus Medical, Inc., intrinsic value ties fair value to sustainable cash generation; with the stock above that level, the snapshot reads as a premium versus fundamentals rather than a pure sentiment call.

Historical valuation for GMED shows cycles where multiples expanded and compressed; today’s positioning rhymes more with growth optimism than the mid-range of its recent history.

Market expectations boil down to growth, risk, and return on capital—current levels bake in strong execution, so disappointments hit harder. Cross-check with live ratios when your API is connected.

Key metrics

P/E ratio: 13.1x
Revenue growth (TTM y/y): 10%
Profit margin: 36.4%
Fair value (model): Unlock

Next steps

Frequently asked questions — GMED

Is GMED overvalued right now?

A stock is overvalued when its market price sits above a reasonable fair value range. Use the live snapshot on this page for GMED, then validate with fundamentals and peer multiples.

What is Globus Medical, Inc.'s intrinsic value?

Our DCF, P/E Multiple, and P/S Multiple models estimate whether GMED trades above or below fair value. At $78.83, Globus Medical, Inc. currently looks undervalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.

How is Globus Medical, Inc.'s intrinsic value calculated?

Tickerplace calculates GMED's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.

Is GMED undervalued right now?

Based on our 2026 valuation models, Globus Medical, Inc. (GMED) appears undervalued at $78.83 with about 35.6% upside to fair value. Treat this as a screen—verify fundamentals on the company profile.

Peers for GMED: open their overvalued / undervalued view.

Instant valuation answer